 | • レポートコード：QY2203B04581 • 出版社/出版日：QYResearch / 2022年3月25日 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User | ￥1,087,800 (USD7,350) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症のパンデミックにより、世界のニコチンアミドリボシド（NR）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にニコチンアミドリボシド（NR）の世界市場のxxx％を占める「医薬品用」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「栄養補助食品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国のニコチンアミドリボシド（NR）の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのニコチンアミドリボシド（NR）市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのニコチンアミドリボシド（NR）市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 ニコチンアミドリボシド（NR）のグローバル主要メーカーには、Chroma Dex、Elysium Health、Tru Niagen、Thorne、Zhejiang Jiahua Pharmchemical、Shenzhen Longgesheng Technology、Bontac Bio-engineeringなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ニコチンアミドリボシド（NR）市場は、種類と用途によって区分されます。世界のニコチンアミドリボシド（NR）市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 医薬品用、食品用、その他 【用途別セグメント】 栄養補助食品、製薬産業、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ニコチンアミドリボシド（NR）製品概要 - 種類別市場（医薬品用、食品用、その他） - 用途別市場（栄養補助食品、製薬産業、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のニコチンアミドリボシド（NR）販売量予測2017-2028 - 世界のニコチンアミドリボシド（NR）売上予測2017-2028 - ニコチンアミドリボシド（NR）の地域別販売量 - ニコチンアミドリボシド（NR）の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ニコチンアミドリボシド（NR）販売量 - 主要メーカー別ニコチンアミドリボシド（NR）売上 - 主要メーカー別ニコチンアミドリボシド（NR）価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（医薬品用、食品用、その他） - ニコチンアミドリボシド（NR）の種類別販売量 - ニコチンアミドリボシド（NR）の種類別売上 - ニコチンアミドリボシド（NR）の種類別価格 ・用途別市場規模（栄養補助食品、製薬産業、その他） - ニコチンアミドリボシド（NR）の用途別販売量 - ニコチンアミドリボシド（NR）の用途別売上 - ニコチンアミドリボシド（NR）の用途別価格 ・北米市場 - 北米のニコチンアミドリボシド（NR）市場規模（種類別、用途別） - 主要国別のニコチンアミドリボシド（NR）市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのニコチンアミドリボシド（NR）市場規模（種類別、用途別） - 主要国別のニコチンアミドリボシド（NR）市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のニコチンアミドリボシド（NR）市場規模（種類別、用途別） - 主要国別のニコチンアミドリボシド（NR）市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のニコチンアミドリボシド（NR）市場規模（種類別、用途別） - 主要国別のニコチンアミドリボシド（NR）市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのニコチンアミドリボシド（NR）市場規模（種類別、用途別） - 主要国別のニコチンアミドリボシド（NR）市場規模（トルコ、サウジアラビア） ・企業情報 Chroma Dex、Elysium Health、Tru Niagen、Thorne、Zhejiang Jiahua Pharmchemical、Shenzhen Longgesheng Technology、Bontac Bio-engineering ・産業チェーン及び販売チャネル分析 - ニコチンアミドリボシド（NR）の産業チェーン分析 - ニコチンアミドリボシド（NR）の原材料 - ニコチンアミドリボシド（NR）の生産プロセス - ニコチンアミドリボシド（NR）の販売及びマーケティング - ニコチンアミドリボシド（NR）の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ニコチンアミドリボシド（NR）の産業動向 - ニコチンアミドリボシド（NR）のマーケットドライバー - ニコチンアミドリボシド（NR）の課題 - ニコチンアミドリボシド（NR）の阻害要因 ・主な調査結果 |
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
Market Analysis and Insights: Global Nicotinamide Ribose (NR) Market
Due to the COVID-19 pandemic, the global Nicotinamide Ribose (NR) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Nicotinamide Ribose (NR) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Dietary Supplement segment is altered to an % CAGR throughout this forecast period.
Nicotinamide riboside (NR) is claimed to be a new form pyridine-nucleoside of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide or NAD+. The metabolism of NR is unique from that of other more commonly known forms of vitamin B3, nicotinamide and nicotinic acid. Specifically, NR has been shown in a pre-clinical study to be the most effective form of vitamin B3 at increasing nicotinamide adenine dinucleotide (NAD+)2.
Global Nicotinamide Ribose (NR) Scope and Segment
Nicotinamide Ribose (NR) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Nicotinamide Ribose (NR) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmaceutical Grade
Food Grade
Other
Segment by Application
Dietary Supplement
Pharmaceutical Industry
Other
By Company
Chroma Dex
Elysium Health
Tru Niagen
Thorne
Zhejiang Jiahua Pharmchemical
Shenzhen Longgesheng Technology
Bontac Bio-engineering
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Nicotinamide Ribose (NR) Product Introduction
1.2 Market by Type
1.2.1 Global Nicotinamide Ribose (NR) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.2.4 Other
1.3 Market by Application
1.3.1 Global Nicotinamide Ribose (NR) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Dietary Supplement
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Nicotinamide Ribose (NR) Sales Estimates and Forecasts 2017-2028
2.2 Global Nicotinamide Ribose (NR) Revenue Estimates and Forecasts 2017-2028
2.3 Global Nicotinamide Ribose (NR) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Nicotinamide Ribose (NR) Sales by Region
2.4.1 Global Nicotinamide Ribose (NR) Sales by Region (2017-2022)
2.4.2 Global Sales Nicotinamide Ribose (NR) by Region (2023-2028)
2.5 Global Nicotinamide Ribose (NR) Revenue by Region
2.5.1 Global Nicotinamide Ribose (NR) Revenue by Region (2017-2022)
2.5.2 Global Nicotinamide Ribose (NR) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Nicotinamide Ribose (NR) Sales by Manufacturers
3.1.1 Global Top Nicotinamide Ribose (NR) Manufacturers by Sales (2017-2022)
3.1.2 Global Nicotinamide Ribose (NR) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Nicotinamide Ribose (NR) in 2021
3.2 Global Nicotinamide Ribose (NR) Revenue by Manufacturers
3.2.1 Global Nicotinamide Ribose (NR) Revenue by Manufacturers (2017-2022)
3.2.2 Global Nicotinamide Ribose (NR) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Nicotinamide Ribose (NR) Revenue in 2021
3.3 Global Nicotinamide Ribose (NR) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Nicotinamide Ribose (NR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Nicotinamide Ribose (NR) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Nicotinamide Ribose (NR) Sales by Type
4.1.1 Global Nicotinamide Ribose (NR) Historical Sales by Type (2017-2022)
4.1.2 Global Nicotinamide Ribose (NR) Forecasted Sales by Type (2023-2028)
4.1.3 Global Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
4.2 Global Nicotinamide Ribose (NR) Revenue by Type
4.2.1 Global Nicotinamide Ribose (NR) Historical Revenue by Type (2017-2022)
4.2.2 Global Nicotinamide Ribose (NR) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
4.3 Global Nicotinamide Ribose (NR) Price by Type
4.3.1 Global Nicotinamide Ribose (NR) Price by Type (2017-2022)
4.3.2 Global Nicotinamide Ribose (NR) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Nicotinamide Ribose (NR) Sales by Application
5.1.1 Global Nicotinamide Ribose (NR) Historical Sales by Application (2017-2022)
5.1.2 Global Nicotinamide Ribose (NR) Forecasted Sales by Application (2023-2028)
5.1.3 Global Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
5.2 Global Nicotinamide Ribose (NR) Revenue by Application
5.2.1 Global Nicotinamide Ribose (NR) Historical Revenue by Application (2017-2022)
5.2.2 Global Nicotinamide Ribose (NR) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
5.3 Global Nicotinamide Ribose (NR) Price by Application
5.3.1 Global Nicotinamide Ribose (NR) Price by Application (2017-2022)
5.3.2 Global Nicotinamide Ribose (NR) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Nicotinamide Ribose (NR) Market Size by Type
6.1.1 North America Nicotinamide Ribose (NR) Sales by Type (2017-2028)
6.1.2 North America Nicotinamide Ribose (NR) Revenue by Type (2017-2028)
6.2 North America Nicotinamide Ribose (NR) Market Size by Application
6.2.1 North America Nicotinamide Ribose (NR) Sales by Application (2017-2028)
6.2.2 North America Nicotinamide Ribose (NR) Revenue by Application (2017-2028)
6.3 North America Nicotinamide Ribose (NR) Market Size by Country
6.3.1 North America Nicotinamide Ribose (NR) Sales by Country (2017-2028)
6.3.2 North America Nicotinamide Ribose (NR) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Nicotinamide Ribose (NR) Market Size by Type
7.1.1 Europe Nicotinamide Ribose (NR) Sales by Type (2017-2028)
7.1.2 Europe Nicotinamide Ribose (NR) Revenue by Type (2017-2028)
7.2 Europe Nicotinamide Ribose (NR) Market Size by Application
7.2.1 Europe Nicotinamide Ribose (NR) Sales by Application (2017-2028)
7.2.2 Europe Nicotinamide Ribose (NR) Revenue by Application (2017-2028)
7.3 Europe Nicotinamide Ribose (NR) Market Size by Country
7.3.1 Europe Nicotinamide Ribose (NR) Sales by Country (2017-2028)
7.3.2 Europe Nicotinamide Ribose (NR) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Nicotinamide Ribose (NR) Market Size by Type
8.1.1 Asia Pacific Nicotinamide Ribose (NR) Sales by Type (2017-2028)
8.1.2 Asia Pacific Nicotinamide Ribose (NR) Revenue by Type (2017-2028)
8.2 Asia Pacific Nicotinamide Ribose (NR) Market Size by Application
8.2.1 Asia Pacific Nicotinamide Ribose (NR) Sales by Application (2017-2028)
8.2.2 Asia Pacific Nicotinamide Ribose (NR) Revenue by Application (2017-2028)
8.3 Asia Pacific Nicotinamide Ribose (NR) Market Size by Region
8.3.1 Asia Pacific Nicotinamide Ribose (NR) Sales by Region (2017-2028)
8.3.2 Asia Pacific Nicotinamide Ribose (NR) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Nicotinamide Ribose (NR) Market Size by Type
9.1.1 Latin America Nicotinamide Ribose (NR) Sales by Type (2017-2028)
9.1.2 Latin America Nicotinamide Ribose (NR) Revenue by Type (2017-2028)
9.2 Latin America Nicotinamide Ribose (NR) Market Size by Application
9.2.1 Latin America Nicotinamide Ribose (NR) Sales by Application (2017-2028)
9.2.2 Latin America Nicotinamide Ribose (NR) Revenue by Application (2017-2028)
9.3 Latin America Nicotinamide Ribose (NR) Market Size by Country
9.3.1 Latin America Nicotinamide Ribose (NR) Sales by Country (2017-2028)
9.3.2 Latin America Nicotinamide Ribose (NR) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Nicotinamide Ribose (NR) Market Size by Type
10.1.1 Middle East and Africa Nicotinamide Ribose (NR) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Nicotinamide Ribose (NR) Revenue by Type (2017-2028)
10.2 Middle East and Africa Nicotinamide Ribose (NR) Market Size by Application
10.2.1 Middle East and Africa Nicotinamide Ribose (NR) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Nicotinamide Ribose (NR) Revenue by Application (2017-2028)
10.3 Middle East and Africa Nicotinamide Ribose (NR) Market Size by Country
10.3.1 Middle East and Africa Nicotinamide Ribose (NR) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Nicotinamide Ribose (NR) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Chroma Dex
11.1.1 Chroma Dex Corporation Information
11.1.2 Chroma Dex Overview
11.1.3 Chroma Dex Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Chroma Dex Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chroma Dex Recent Developments
11.2 Elysium Health
11.2.1 Elysium Health Corporation Information
11.2.2 Elysium Health Overview
11.2.3 Elysium Health Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Elysium Health Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Elysium Health Recent Developments
11.3 Tru Niagen
11.3.1 Tru Niagen Corporation Information
11.3.2 Tru Niagen Overview
11.3.3 Tru Niagen Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Tru Niagen Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Tru Niagen Recent Developments
11.4 Thorne
11.4.1 Thorne Corporation Information
11.4.2 Thorne Overview
11.4.3 Thorne Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thorne Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thorne Recent Developments
11.5 Zhejiang Jiahua Pharmchemical
11.5.1 Zhejiang Jiahua Pharmchemical Corporation Information
11.5.2 Zhejiang Jiahua Pharmchemical Overview
11.5.3 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Jiahua Pharmchemical Recent Developments
11.6 Shenzhen Longgesheng Technology
11.6.1 Shenzhen Longgesheng Technology Corporation Information
11.6.2 Shenzhen Longgesheng Technology Overview
11.6.3 Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Shenzhen Longgesheng Technology Recent Developments
11.7 Bontac Bio-engineering
11.7.1 Bontac Bio-engineering Corporation Information
11.7.2 Bontac Bio-engineering Overview
11.7.3 Bontac Bio-engineering Nicotinamide Ribose (NR) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bontac Bio-engineering Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bontac Bio-engineering Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Nicotinamide Ribose (NR) Industry Chain Analysis
12.2 Nicotinamide Ribose (NR) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Nicotinamide Ribose (NR) Production Mode & Process
12.4 Nicotinamide Ribose (NR) Sales and Marketing
12.4.1 Nicotinamide Ribose (NR) Sales Channels
12.4.2 Nicotinamide Ribose (NR) Distributors
12.5 Nicotinamide Ribose (NR) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Nicotinamide Ribose (NR) Industry Trends
13.2 Nicotinamide Ribose (NR) Market Drivers
13.3 Nicotinamide Ribose (NR) Market Challenges
13.4 Nicotinamide Ribose (NR) Market Restraints
14 Key Findings in The Global Nicotinamide Ribose (NR) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Nicotinamide Ribose (NR) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Pharmaceutical Grade
Table 3. Major Manufacturers of Food Grade
Table 4. Major Manufacturers of Other
Table 5. Global Nicotinamide Ribose (NR) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Nicotinamide Ribose (NR) Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Nicotinamide Ribose (NR) Sales by Region (2017-2022) & (MT)
Table 8. Global Nicotinamide Ribose (NR) Sales Market Share by Region (2017-2022)
Table 9. Global Nicotinamide Ribose (NR) Sales by Region (2023-2028) & (MT)
Table 10. Global Nicotinamide Ribose (NR) Sales Market Share by Region (2023-2028)
Table 11. Global Nicotinamide Ribose (NR) Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Nicotinamide Ribose (NR) Revenue Market Share by Region (2017-2022)
Table 13. Global Nicotinamide Ribose (NR) Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Nicotinamide Ribose (NR) Revenue Market Share by Region (2023-2028)
Table 15. Global Nicotinamide Ribose (NR) Sales by Manufacturers (2017-2022) & (MT)
Table 16. Global Nicotinamide Ribose (NR) Sales Share by Manufacturers (2017-2022)
Table 17. Global Nicotinamide Ribose (NR) Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Nicotinamide Ribose (NR) Revenue Share by Manufacturers (2017-2022)
Table 19. Nicotinamide Ribose (NR) Price by Manufacturers (2017-2022) &(US$/Kg)
Table 20. Global Nicotinamide Ribose (NR) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Nicotinamide Ribose (NR) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Ribose (NR) as of 2021)
Table 22. Nicotinamide Ribose (NR) Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Nicotinamide Ribose (NR) Product Offered
Table 24. Date of Manufacturers Enter into Nicotinamide Ribose (NR) Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 27. Global Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 28. Global Nicotinamide Ribose (NR) Sales Share by Type (2017-2022)
Table 29. Global Nicotinamide Ribose (NR) Sales Share by Type (2023-2028)
Table 30. Global Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Nicotinamide Ribose (NR) Revenue Share by Type (2017-2022)
Table 33. Global Nicotinamide Ribose (NR) Revenue Share by Type (2023-2028)
Table 34. Nicotinamide Ribose (NR) Price by Type (2017-2022) & (US$/Kg)
Table 35. Global Nicotinamide Ribose (NR) Price Forecast by Type (2023-2028) & (US$/Kg)
Table 36. Global Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 37. Global Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 38. Global Nicotinamide Ribose (NR) Sales Share by Application (2017-2022)
Table 39. Global Nicotinamide Ribose (NR) Sales Share by Application (2023-2028)
Table 40. Global Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Nicotinamide Ribose (NR) Revenue Share by Application (2017-2022)
Table 43. Global Nicotinamide Ribose (NR) Revenue Share by Application (2023-2028)
Table 44. Nicotinamide Ribose (NR) Price by Application (2017-2022) & (US$/Kg)
Table 45. Global Nicotinamide Ribose (NR) Price Forecast by Application (2023-2028) & (US$/Kg)
Table 46. North America Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 47. North America Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 48. North America Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 51. North America Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 52. North America Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Nicotinamide Ribose (NR) Sales by Country (2017-2022) & (MT)
Table 55. North America Nicotinamide Ribose (NR) Sales by Country (2023-2028) & (MT)
Table 56. North America Nicotinamide Ribose (NR) Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Nicotinamide Ribose (NR) Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 59. Europe Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 60. Europe Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 63. Europe Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 64. Europe Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Nicotinamide Ribose (NR) Sales by Country (2017-2022) & (MT)
Table 67. Europe Nicotinamide Ribose (NR) Sales by Country (2023-2028) & (MT)
Table 68. Europe Nicotinamide Ribose (NR) Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Nicotinamide Ribose (NR) Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 71. Asia Pacific Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 72. Asia Pacific Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 75. Asia Pacific Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 76. Asia Pacific Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Nicotinamide Ribose (NR) Sales by Region (2017-2022) & (MT)
Table 79. Asia Pacific Nicotinamide Ribose (NR) Sales by Region (2023-2028) & (MT)
Table 80. Asia Pacific Nicotinamide Ribose (NR) Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Nicotinamide Ribose (NR) Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 83. Latin America Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 84. Latin America Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 87. Latin America Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 88. Latin America Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Nicotinamide Ribose (NR) Sales by Country (2017-2022) & (MT)
Table 91. Latin America Nicotinamide Ribose (NR) Sales by Country (2023-2028) & (MT)
Table 92. Latin America Nicotinamide Ribose (NR) Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Nicotinamide Ribose (NR) Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Nicotinamide Ribose (NR) Sales by Type (2017-2022) & (MT)
Table 95. Middle East and Africa Nicotinamide Ribose (NR) Sales by Type (2023-2028) & (MT)
Table 96. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Nicotinamide Ribose (NR) Sales by Application (2017-2022) & (MT)
Table 99. Middle East and Africa Nicotinamide Ribose (NR) Sales by Application (2023-2028) & (MT)
Table 100. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Nicotinamide Ribose (NR) Sales by Country (2017-2022) & (MT)
Table 103. Middle East and Africa Nicotinamide Ribose (NR) Sales by Country (2023-2028) & (MT)
Table 104. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Nicotinamide Ribose (NR) Revenue by Country (2023-2028) & (US$ Million)
Table 106. Chroma Dex Corporation Information
Table 107. Chroma Dex Description and Major Businesses
Table 108. Chroma Dex Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 109. Chroma Dex Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Chroma Dex Recent Developments
Table 111. Elysium Health Corporation Information
Table 112. Elysium Health Description and Major Businesses
Table 113. Elysium Health Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 114. Elysium Health Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. Elysium Health Recent Developments
Table 116. Tru Niagen Corporation Information
Table 117. Tru Niagen Description and Major Businesses
Table 118. Tru Niagen Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 119. Tru Niagen Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Tru Niagen Recent Developments
Table 121. Thorne Corporation Information
Table 122. Thorne Description and Major Businesses
Table 123. Thorne Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 124. Thorne Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Thorne Recent Developments
Table 126. Zhejiang Jiahua Pharmchemical Corporation Information
Table 127. Zhejiang Jiahua Pharmchemical Description and Major Businesses
Table 128. Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 129. Zhejiang Jiahua Pharmchemical Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Zhejiang Jiahua Pharmchemical Recent Developments
Table 131. Shenzhen Longgesheng Technology Corporation Information
Table 132. Shenzhen Longgesheng Technology Description and Major Businesses
Table 133. Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 134. Shenzhen Longgesheng Technology Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Shenzhen Longgesheng Technology Recent Developments
Table 136. Bontac Bio-engineering Corporation Information
Table 137. Bontac Bio-engineering Description and Major Businesses
Table 138. Bontac Bio-engineering Nicotinamide Ribose (NR) Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 139. Bontac Bio-engineering Nicotinamide Ribose (NR) Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Bontac Bio-engineering Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Raw Materials Key Suppliers Lists
Table 143. Nicotinamide Ribose (NR) Distributors List
Table 144. Nicotinamide Ribose (NR) Customers List
Table 145. Nicotinamide Ribose (NR) Market Trends
Table 146. Nicotinamide Ribose (NR) Market Drivers
Table 147. Nicotinamide Ribose (NR) Market Challenges
Table 148. Nicotinamide Ribose (NR) Market Restraints
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Nicotinamide Ribose (NR) Product Picture
Figure 3. Global Nicotinamide Ribose (NR) Market Share by Type in 2021 & 2028
Figure 3. Pharmaceutical Grade Product Picture
Figure 4. Food Grade Product Picture
Figure 5. Other Product Picture
Figure 6. Global Nicotinamide Ribose (NR) Market Share by Application in 2021 & 2028
Figure 7. Dietary Supplement
Figure 8. Pharmaceutical Industry
Figure 9. Other
Figure 10. Nicotinamide Ribose (NR) Report Years Considered
Figure 11. Global Nicotinamide Ribose (NR) Sales 2017-2028 (MT)
Figure 12. Global Nicotinamide Ribose (NR) Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Nicotinamide Ribose (NR) Revenue 2017-2028 (US$ Million)
Figure 14. Global Nicotinamide Ribose (NR) Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Nicotinamide Ribose (NR) Sales Market Share by Region (2017-2022)
Figure 16. Global Nicotinamide Ribose (NR) Sales Market Share by Region (2023-2028)
Figure 17. North America Nicotinamide Ribose (NR) Sales YoY (2017-2028) & (MT)
Figure 18. North America Nicotinamide Ribose (NR) Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Nicotinamide Ribose (NR) Sales YoY (2017-2028) & (MT)
Figure 20. Europe Nicotinamide Ribose (NR) Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Nicotinamide Ribose (NR) Sales YoY (2017-2028) & (MT)
Figure 22. Asia-Pacific Nicotinamide Ribose (NR) Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Nicotinamide Ribose (NR) Sales YoY (2017-2028) & (MT)
Figure 24. Latin America Nicotinamide Ribose (NR) Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Nicotinamide Ribose (NR) Sales YoY (2017-2028) & (MT)
Figure 26. Middle East & Africa Nicotinamide Ribose (NR) Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Nicotinamide Ribose (NR) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Nicotinamide Ribose (NR) in the World: Market Share by Nicotinamide Ribose (NR) Revenue in 2021
Figure 29. Global Nicotinamide Ribose (NR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 31. Global Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 32. Global Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 33. Global Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 34. North America Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 35. North America Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 36. North America Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 37. North America Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 38. North America Nicotinamide Ribose (NR) Sales Share by Country (2017-2028)
Figure 39. North America Nicotinamide Ribose (NR) Revenue Share by Country (2017-2028)
Figure 40. U.S. Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 41. Canada Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 42. Europe Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 43. Europe Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 44. Europe Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 45. Europe Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 46. Europe Nicotinamide Ribose (NR) Sales Share by Country (2017-2028)
Figure 47. Europe Nicotinamide Ribose (NR) Revenue Share by Country (2017-2028)
Figure 48. Germany Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 49. France Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 50. U.K. Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 51. Italy Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 52. Russia Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 53. Asia Pacific Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 54. Asia Pacific Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 55. Asia Pacific Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 56. Asia Pacific Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 57. Asia Pacific Nicotinamide Ribose (NR) Sales Share by Region (2017-2028)
Figure 58. Asia Pacific Nicotinamide Ribose (NR) Revenue Share by Region (2017-2028)
Figure 59. China Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 60. Japan Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 61. South Korea Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 62. India Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 63. Australia Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 64. Taiwan Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 65. Indonesia Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 66. Thailand Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 67. Malaysia Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 68. Philippines Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 70. Latin America Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 72. Latin America Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Nicotinamide Ribose (NR) Sales Share by Country (2017-2028)
Figure 74. Latin America Nicotinamide Ribose (NR) Revenue Share by Country (2017-2028)
Figure 75. Mexico Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Nicotinamide Ribose (NR) Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Nicotinamide Ribose (NR) Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Nicotinamide Ribose (NR) Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Nicotinamide Ribose (NR) Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Nicotinamide Ribose (NR) Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Nicotinamide Ribose (NR) Revenue Share by Country (2017-2028)
Figure 84. Turkey Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Nicotinamide Ribose (NR) Revenue (2017-2028) & (US$ Million)
Figure 87. Nicotinamide Ribose (NR) Value Chain
Figure 88. Nicotinamide Ribose (NR) Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed